| 000 | 01622 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516130337.0 | ||
| 264 | 0 | _c20130219 | |
| 008 | 201302s 0 0 eng d | ||
| 022 | _a1535-7228 | ||
| 024 | 7 |
_a10.1176/appi.ajp.2012.12070965 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEsseveld, Maite M | |
| 245 | 0 | 0 |
_aDrawings during neuropsychiatric recovery from anti-NMDA receptor encephalitis. _h[electronic resource] |
| 260 |
_bThe American journal of psychiatry _cJan 2013 |
||
| 300 |
_a21-2 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArt Therapy _xmethods |
| 650 | 0 | 4 |
_aAutoimmune Diseases of the Nervous System _ximmunology |
| 650 | 0 | 4 |
_aCognition Disorders _ximmunology |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEncephalitis _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization, Passive |
| 650 | 0 | 4 | _aMental Status Schedule |
| 650 | 0 | 4 |
_aMethylprednisolone _xtherapeutic use |
| 650 | 0 | 4 |
_aNeurocognitive Disorders _ximmunology |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _ximmunology |
| 650 | 0 | 4 | _aRituximab |
| 700 | 1 | _avan de Riet, Emma H C W | |
| 700 | 1 | _aCuypers, Leen | |
| 700 | 1 | _aSchieveld, Jan N M | |
| 773 | 0 |
_tThe American journal of psychiatry _gvol. 170 _gno. 1 _gp. 21-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1176/appi.ajp.2012.12070965 _zAvailable from publisher's website |
| 999 |
_c22391966 _d22391966 |
||